VITALITY Ecosystem Funds preclinics Italia in Biotech Consortium for Antibody Development
24 Febbraio 2023
preclinics Italia, along with its partners Diatheva and Toscana Life Sciences, has secured funding for the innovative PISAMUNAB project, aimed at revolutionizing the landscape of antibody-based diagnostic and therapeutic solutions. The project, titled Integrated platform for the development of human monoclonal antibodies and nanobodies for biomedical applications, seeks to accelerate